Andreas Halvorsen - Viking Global Investors
Holding/activity history for Jazz Pharmaceuticals plc (JAZZ)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2019 Q2 | 0 | 0.00 | Sell 100.00% | 0.52 | SEC | ||
| 2019 Q1 | 635,736 | 0.52 | Reduce 30.67% | 0.20 | $142.95 | $90,878,000 | SEC |
| 2018 Q4 | 916,992 | 0.66 | Reduce 3.50% | 0.03 | $123.96 | $113,670,000 | SEC |
| 2018 Q3 | 950,281 | 0.92 | Add 1.50% | 0.01 | $168.13 | $159,771,000 | SEC |
| 2018 Q2 | 936,195 | 0.97 | Add 21.60% | 0.17 | $172.30 | $161,306,000 | SEC |
| 2018 Q1 | 769,888 | 0.72 | Reduce 14.58% | 0.11 | $150.99 | $116,245,000 | SEC |
| 2017 Q4 | 901,337 | 0.77 | Reduce 24.73% | 0.29 | $134.65 | $121,365,000 | SEC |
| 2017 Q3 | 1,197,466 | 1.18 | Add 20.60% | 0.20 | $146.25 | $175,129,000 | SEC |
| 2017 Q2 | 992,901 | 1.06 | Add 401.90% | 0.85 | $155.50 | $154,396,000 | SEC |
| 2017 Q1 | 197,830 | 0.13 | Buy | 0.13 | $145.13 | $28,711,000 | SEC |
| 2016 Q4 | 0 | 0.00 | Sell 100.00% | 0.40 | SEC | ||
| 2016 Q3 | 737,623 | 0.40 | Add 19.19% | 0.06 | $121.48 | $89,606,000 | SEC |
| 2016 Q2 | 618,862 | 0.38 | Buy | 0.38 | $141.31 | $87,451,000 | SEC |